Sivik Global Healthcare’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-15,000
Closed -$2.44M 46
2024
Q4
$2.44M Buy
+15,000
New +$2.68M 1.29% 30
2020
Q1
Sell
-40,000
Closed -$5.29M 59
2019
Q4
$5.29M Buy
40,000
+10,000
+33% +$1.24M 1.97% 27
2019
Q3
$3.74M Buy
+30,000
New +$3.62M 1.89% 29
2018
Q3
Sell
-55,000
Closed -$4.68M 68
2018
Q2
$4.68M Buy
55,000
+15,000
+38% +$1.27M 1.8% 25
2018
Q1
$3.34M Sell
40,000
-20,000
-33% -$1.58M 1.56% 29
2017
Q4
$4.32M Sell
60,000
-5,000
-8% -$343K 1.6% 28
2017
Q3
$4.14M Buy
+65,000
New +$4.07M 1.41% 29
2016
Q4
Sell
-35,000
Closed -$1.82M 65
2016
Q3
$1.82M Buy
+35,000
New +$1.77M 0.92% 38
2016
Q1
Sell
-45,000
Closed -$2.16M 67
2015
Q4
$2.16M Sell
45,000
-10,000
-18% -$452K 1.02% 45
2015
Q3
$2.27M Buy
55,000
+5,000
+10% +$232K 1.1% 36
2015
Q2
$2.41M Hold
50,000
0.84% 49
2015
Q1
$2.31M Sell
50,000
-19,400
-28% -$875K 0.79% 57
2014
Q4
$2.99M Buy
69,400
+9,400
+16% +$381K 1.21% 40
2014
Q3
$2.22M Buy
+60,000
New +$2.05M 1.01% 51

Other funds holding ZTS

Sivik Global Healthcare's ZTS Position: Q1 2025 in Review

Sivik Global Healthcare sold out of Zoetis (ZTS) in Q1 2025, closing a stake of 15,000 shares — an estimated $2.44M sold.

Sivik Global Healthcare first reported a position in ZTS in Q3 2014 and held it in 14 quarters. The position peaked at $5.29M in Q4 2019. 1,886 funds tracked by Wall St. Rank hold ZTS as of Q1 2025.

  • Sivik Global Healthcare reported no remaining Zoetis position as of Q1 2025 after selling out during the quarter.
  • Sivik Global Healthcare sold 15,000 Zoetis shares in Q1 2025, an estimated $2.44M.
  • Sivik Global Healthcare first reported a position in Zoetis in Q3 2014 and held it in 14 quarters.
  • Sivik Global Healthcare's Zoetis position peaked at $5.29M in Q4 2019.
  • 1,886 funds tracked by Wall St. Rank held Zoetis as of Q1 2025.

Based on Sivik Global Healthcare's 13F filing for Q1 2025, filed 22 Apr 2025.